Rapid CommunicationShort Communication
Intracellular Catabolism of an Antibody Drug Conjugate with a Noncleavable Linker
Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
Drug Metabolism and Disposition September 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253
Brooke M. Rock
Department of Pharmacokinetics and Drug Metabolism (B.M.R., D.A.R., S.K.P.) and Therapeutic Innovation Unit (K.J.H., M.E.T., W.C.F.), Amgen, Inc., Seattle, Washington
Mark E. Tometsko
Department of Pharmacokinetics and Drug Metabolism (B.M.R., D.A.R., S.K.P.) and Therapeutic Innovation Unit (K.J.H., M.E.T., W.C.F.), Amgen, Inc., Seattle, Washington
Sonal K. Patel
Department of Pharmacokinetics and Drug Metabolism (B.M.R., D.A.R., S.K.P.) and Therapeutic Innovation Unit (K.J.H., M.E.T., W.C.F.), Amgen, Inc., Seattle, Washington
Kevin J. Hamblett
Department of Pharmacokinetics and Drug Metabolism (B.M.R., D.A.R., S.K.P.) and Therapeutic Innovation Unit (K.J.H., M.E.T., W.C.F.), Amgen, Inc., Seattle, Washington
William C. Fanslow
Department of Pharmacokinetics and Drug Metabolism (B.M.R., D.A.R., S.K.P.) and Therapeutic Innovation Unit (K.J.H., M.E.T., W.C.F.), Amgen, Inc., Seattle, Washington
Dan A. Rock
Department of Pharmacokinetics and Drug Metabolism (B.M.R., D.A.R., S.K.P.) and Therapeutic Innovation Unit (K.J.H., M.E.T., W.C.F.), Amgen, Inc., Seattle, Washington

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Rapid CommunicationShort Communication
In Vitro Catabolism of a Noncleavable ADC
Brooke M. Rock, Mark E. Tometsko, Sonal K. Patel, Kevin J. Hamblett, William C. Fanslow and Dan A. Rock
Drug Metabolism and Disposition September 1, 2015, 43 (9) 1341-1344; DOI: https://doi.org/10.1124/dmd.115.064253
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement